Table 5 Signature comparing controls with cases with active disease in the follow-up. Final model
From: Circulating miRNAs signature on breast cancer: the MCC-Spain project
miRNA | TMM controls* | TMM cases* | P-value* | Fold change* | Odds ratio (95% CI)** | P** |
|---|---|---|---|---|---|---|
MiR-101-3p | 1.959 | 1.364 | 3*10^− 8 | 0.662 | 0.22 (0.12, 0.43) |  < 0.001 |
MiR-423-3p | − 1.283 | − 0.878 | 2*10^− 5 | 1.324 | 1.78 (0.80, 3.95) | 0.16 |
MiR-139-5p | − 4.454 | − 3.911 | 0.0003 | 1.457 | 1.26 (0.80, 1.97) | 0.32 |
MiR-1307-3p | − 4.742 | − 4.176 | 6*10^− 5 | 1.480 | 1.49 (0.92, 2.42) | 0.11 |
MiR-331-3p | − 3.818 | − 3.413 | 0.0007 | 1.324 | 1.81 (0.98, 3.35) | 0.06 |
MiR-21-3p | − 4.978 | − 4.508 | 0.0006 | 1.385 | 1.42 (1.06, 1.91) | 0.02 |